These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10154864)

  • 21. Medicare payment for new technologies. Can the process be improved despite conflicting goals? An ECRI technology management assessment.
    J Health Care Technol; 1986; 3(1):13-32. PubMed ID: 10300959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medicare program; withdrawal of coverage of extracranial-intracranial arterial bypass surgery for the treatment or prevention of stroke--HCFA. Final notice.
    Fed Regist; 1991 Feb; 56(39):8206-8. PubMed ID: 10110282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver transplant coverage weighed.
    Lutz S
    Mod Healthc; 1988 Dec; 18(51):35. PubMed ID: 10303034
    [No Abstract]   [Full Text] [Related]  

  • 24. New obstacles in the path of marketing new medical devices.
    Bucci VA; Reiss JB; Hall NC
    J Health Care Technol; 1985; 2(2):81-96. PubMed ID: 10300491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small miracles: point-of-care testing.
    Wick JY
    Consult Pharm; 2010 Jul; 25(7):416-8, 425-31. PubMed ID: 20601347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Groups to Congress: hasten review of lung surgery.
    Weissenstein E
    Mod Healthc; 1996 Aug; 26(32):72. PubMed ID: 10158985
    [No Abstract]   [Full Text] [Related]  

  • 27. Medicare to pay for new technologies in hospital inpatient settings.
    Gundling RL
    Healthc Financ Manage; 2001 Nov; 55(11):70-2. PubMed ID: 11715384
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost effectiveness as a criterion for Medicare coverage.
    Leaf A
    N Engl J Med; 1989 Sep; 321(13):898-900. PubMed ID: 2505078
    [No Abstract]   [Full Text] [Related]  

  • 29. The limited state of technology assessment for medical devices: facing the issues.
    Ramsey SD; Luce BR; Deyo R; Franklin G
    Am J Manag Care; 1998 Sep; 4 Spec No():SP188-99. PubMed ID: 10185994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The disconnect between the HCFA and the FDA.
    Firth BG
    J Invasive Cardiol; 2001 Feb; 13(2):136-8; discussion 158-70. PubMed ID: 11176025
    [No Abstract]   [Full Text] [Related]  

  • 31. Medicare program; withdrawal of coverage of thermography--HCFA. Final notice.
    Fed Regist; 1992 Nov; 57(225):54798-825. PubMed ID: 10122879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dollars and stents: is reimbursement floating out of reach?
    Rohland P
    J Cardiovasc Manag; 1999; 10(6):16-7. PubMed ID: 10662365
    [No Abstract]   [Full Text] [Related]  

  • 33. Technology faces HCFA cost test.
    Wagner L
    Mod Healthc; 1991 Apr; 21(17):4. PubMed ID: 10113580
    [No Abstract]   [Full Text] [Related]  

  • 34. Using the MADIT II criteria for implantable cardioverter defibrillators-what is the role of the Food and Drug Administration approval?
    Barold HS
    Card Electrophysiol Rev; 2003 Dec; 7(4):443-6. PubMed ID: 15071272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion of new technologies. Can Medicare payment decisions be made faster and more efficiently?
    VanAntwerp M
    J Health Care Technol; 1985; 2(2):97-103. PubMed ID: 10300492
    [No Abstract]   [Full Text] [Related]  

  • 36. Technology assessment of medical devices at the Center for Devices and Radiological Health.
    Kessler L; Richter K
    Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in medical technology: legal problems and approaches.
    Millman DS
    Caring; 1985 Jan; 4(1):11-8. PubMed ID: 10299993
    [No Abstract]   [Full Text] [Related]  

  • 38. What a Food and Drug lawyer should know about the Medicare Modernization Act.
    Azar AM
    Food Drug Law J; 2004; 59(2):217-22. PubMed ID: 15318393
    [No Abstract]   [Full Text] [Related]  

  • 39. Medicare and Medicaid programs; quarterly listing of program issuances--second quarter, 1998--HCFA. Notice.
    Fed Regist; 1998 Dec; 63(236):67899-908. PubMed ID: 10187556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost and effectiveness: approval and payment for Pulverizer.
    Riegelman R
    Md Med; 2002; 3(3):50-4. PubMed ID: 12214498
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.